STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1806 by analyst upside · 2026-06-27
CBLL
CeriBell, Inc.
Healthcare · Market Cap $758M · P/E 0x
ANALYST PRICE TARGET
+34.4%
implied upside to consensus target
Current Price $19.98
Consensus Target $26.86
Bull Target $32.0
Bear Target $24.0
Analysts Covering 7
ANALYST CONSENSUS — BUY
Strong Buy
1
Buy
6
Hold
0
Sell
0
52-Week Low $10.85
52-Week High $24.33
YTD Return -6.2%
FUNDAMENTALS
Market Cap $758M
P/E Ratio (TTM) N/A
Forward P/E -18.2x
EPS (TTM) $-1.62
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $95M
Profit Margin -63.5%
52-WEEK RANGE
52-Week Low $10.85
52-Week High $24.33
Current Price $19.98
Bear Target $24.0
Bull Target $32.0
● Now $19.98 ● Target $26.86
TRADING DATA
Avg Volume 304K
YTD Return -6.2%
Analyst Count 7
Consensus Buy
Upside to Target +34.4%
Last Updated 2026-06-27

ANALYST SUMMARY

CeriBell, Inc. (CBLL) is currently trading at $19.98 with a Wall Street consensus price target of $26.86, implying potential upside of 34.4% over the next 12 months. 7 analysts currently cover CBLL, with a consensus rating of Buy — 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $32.0, while the most cautious has a target of $24.0.

CBLL operates in the Healthcare sector with a market capitalisation of $758M. The stock is down 6.2% year-to-date and is currently trading near the upper end of its 52-week range of $10.85 – $24.33.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for CBLL, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Canaccord Genuity — Reiterated
Buy → Buy 2026-05-12 Building track record
BTIG reit
Buy → Buy 2026-01-28 38% win rate (8 calls)
Canaccord Genuity — Reiterated
Buy → Buy 2025-12-17 Building track record
BTIG reit
Buy → Buy 2025-12-15 38% win rate (8 calls)
JP Morgan — Reiterated
Overweight → Overweight 2025-11-05 43% win rate (7 calls)
TD Cowen — Reiterated
Buy → Buy 2025-11-05 Building track record
Raymond James ● Initiated
Strong Buy 2025-10-21 Building track record
Ladenburg Thalmann ● Initiated
Buy 2025-04-04 25% win rate (8 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
out of 100
Coverage depth
0/30
Consensus clarity
0/30
Vote unanimity
0/25
Rating stability
0/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call — not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →